Latest News and Press Releases

SERB Pharmaceuticals to acquire development and commercialisation rights to Idefirix® (imlifidase) in Europe and MENA from Hansa Biopharma for €115 million

SANTA MONICA, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- JAKKS Pacific, Inc. (NASDAQ: JAKK) a leading designer, manufacturer and marketer of toys and consumer products, has renewed and extended its...

Terra Innovatum Global N.V. (NASDAQ: NKLR) Secures Water-Independent Cooling Solution for SOLO™ Reactor Through Supply Agreement with SPG Dry Cooling

Context announces buyout of CT-202 future milestones and royalties in exchange for a fully paid-up, non-terminable license Phase 1 initiation for CT-202 trial expected in third quarter of 2026 ...

Licensing Expo returns to Las Vegas May 19-21 with an exceptional lineup of more than 400 brands and extensive education, convening the entire industry

NEW PROVIDENCE, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- Horizon Group USA, a leading force in creative play and DIY innovation, has announced its latest licensing agreement with the world’s most...

PharmAla announces signed definitive agreement to form a special purpose vehicle to spin out APA-01 entity for development, partnering with Diteba

STS Digital Granted Full Bermuda “F” Licence in Landmark Step for Institutional Digital Asset Markets

20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina

Adeia and Google Renew Multi-Year IP License Agreement